AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2008
May 9, 2008
30718_dirs_2008-05-09_a0038ef9-7bef-4551-8b87-c493bfe1be28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2008-05-08
Reporting Person: VERONNEAU MARCEL (VP-Hematology operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-05-08 | Common Stock | F | 330 | $73.53 | Disposed | 30114 | Direct |
| 2008-05-08 | Common Stock | M | 748 | $32.5 | Acquired | 30862 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-05-08 | Employee stock option | $32.5 | M | 748 | Disposed | 2008-06-30 | Common Stock (748) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6476 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option | $56.83 | 2014-07-26 | Common Stock (510) | 510 | Direct |
| Employee stock option | $49.43 | 2013-07-27 | Common Stock (567) | 567 | Direct |
| Employee stock options | $51.6 | 2012-08-17 | Common Stock (475) | 475 | Direct |
| Employee stock option | $37.011 | 2010-11-30 | Common Stock (15000) | 15000 | Direct |
| Employee stock option | $40.47 | 2011-07-08 | Common Stock (505) | 505 | Direct |
| Employee stock option | $33.85 | 2010-08-13 | Common Stock (670) | 670 | Direct |
| Employee stock option | $28.22 | 2009-06-30 | Common Stock (785) | 785 | Direct |
Footnotes
F1: Exercisable 5000 each on 12/1/03, 12/1/04 and 12/1/05
More from BIO-TECHNE Corp
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4
Regulatory Filings
2026
Feb 4